Ebola: Intrigue and Profits Behind the Headlines

… The United States government now owns the patent on Ebola

This plot gets even more interesting when you realize that a patent on Ebola was awarded to the United States government just five years ago, in 2009.

That patent, number CA2741523A1, is available here.

Astonishingly, the patent claims U.S. government ownership over all variants of Ebola which share 70% or more of the protein sequences described in the patent: “[CLAIMS] …a nucleotide sequence of at least 70%-99% identity to the SEQ ID…”

Furthermore, the patent also claims ownership over any and all Ebola viruses which are “weakened” or “killed,” meaning the United States government is literally claiming ownership over all Ebola vaccines.

What this means, of course, is that the U.S. government can demand royalties on all Ebola vaccines.

Even more Orwellian is the fact that the U.S. government can use this patent to halt all other research for treatments or cures for Ebola.

Patent monopoly gives U.S. government legal right to block all non-vaccine Ebola treatments, cures or research

Do you remember the massive medical controversy over the BRCA1 gene tied to breast cancer in women? One corporation claimed patent ownership over the gene and then they used that patent to shut down all other research, testing or diagnosis of breast cancer related to that gene. To date, nearly 20% of the human genome has been claimed as “owned” by corporations, universities and even the government.

The controversy went all the way to the U.S. Supreme Court which ultimately ruled that human genes cannot be patented. But the Supreme Court decision actually protected patents on gene sequences for viruses and other pathogens.

The truth of the matter is that anyone who owns the Ebola gene patent can legally use that patent to shut down all research on Ebola, including research for non-vaccine medical treatments and cures. This is how medical monopolies are reinforced: by monopolizing all the research and all the “cures.” …


Elsewhere in the article the author claims that the timetable for the introduction of the test vaccine is implausible, apparently based on the idea that research only began after the most recent outbreak.  This is silly, if the US government got a patent on it in 2009 it’s obviously been seen as a top research priority for longer than that.   In fact Nature has an article about human testing from 2004: http://www.nature.com/nri/journal/v4/n1/full/nri1282.html .  Still, the above argument makes sense to me and would certainly facilitate the mass depopulation agenda that we know has been in the works for years.

Also see: http://thoughtcrimeradio.net/2014/08/us-has-cure-for-ebola-infection/

One thought on “Ebola: Intrigue and Profits Behind the Headlines”

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.